SCHEMBL470412

SCHEMBL470412

Bc1cc2nc(C)c(CC(=O)OC)c(Cl)n2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 6/20 0.40
GAA P10253 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4E B2RXH2 10/20 0.39
KDM5B Q9UGL1 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
DCTPP1 Q9H773 1/20 0.36
HSD17B10 Q99714 3/20 0.35
TP53 P04637 2/20 0.35
HPGD P15428 2/20 0.35
USP2 O75604 1/20 0.35
RECQL P46063 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL470423 0.86 MAPT (0.41) MAPTPOLBALDH1A1GAASMN1; SMN2
SCHEMBL461816 0.86 KDM4E (0.40) MAPTPOLBALDH1A1GAASMN1; SMN2
SCHEMBL2051557 0.83 AURKA (0.46) MAPTPOLBALDH1A1GAASMN1; SMN2
SCHEMBL2040225 0.82 MAPT (0.39) MAPTPOLBALDH1A1GAASMN1; SMN2
SCHEMBL459359 0.81 MAPT (0.52) MAPTPOLBALDH1A1GAASMN1; SMN2
SCHEMBL2044748 0.80 KDM4E (0.42) MAPTPOLBALDH1A1GAASMN1; SMN2
SCHEMBL461080 0.78 DPP4 (0.52) MAPTPOLBALDH1A1SMN1; SMN2KMT2A
SCHEMBL2045496 0.77 DPP4 (0.52) MAPTPOLBALDH1A1GAASMN1; SMN2
SCHEMBL15475631 0.76 NPC1 (0.52) MAPTPOLBALDH1A1SMN1; SMN2MEN1
SCHEMBL462711 0.74 MAPT (0.46) MAPTPOLBALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed